SEC ownership of ABVC BIOPHARMA, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001173313.

Comparable stake leader

Eugene Jiang

Disclosed value leader

Lind Global Fund II LP

Comparable rows

16/26

Latest evidence

30 Jun 2026

Top shareholders Insider holders Latest transactions

Public ticker: ABVC on Nasdaq
Parsed ownership sources: 13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder: Eugene Jiang
Ranking: Comparable ownership first, then disclosed value
Comparable ownership rows: 16 of 26
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder: Eugene Jiang
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date: 30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer CIK: 0001173313
Issuer location: Fremont, CA

Ownership snapshot

Top shareholders of ABVC BIOPHARMA, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Eugene Jiang

Disclosed value leader

Lind Global Fund II LP

Comparable rows

16/26

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 18% 10 rows are not safely comparable across share classes. 13D/G row: Eugene Jiang Showing 1-8 of 26 holder rows.

Quick read

Eugene Jiang leads the comparable SEC ownership view at 18%.

16 of 26 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Eugene Jiang's linked filing trail.

Comparable ownership Top 5

Eugene Jiang 18%

Lind Global Fund II LP 3.2%

VANGUARD CAPITAL MANAGEMENT LLC 2.2%

GEODE CAPITAL MANAGEMENT, LLC 1.3%

VANGUARD FIDUCIARY TRUST CO 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 26 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Eugene Jiang	13D/G 3/4/5 Chairman of the Board & CBO, Director 13D/G 3/4/5	18%	$219,036 131,159 shares	$0	10 Jul 2025
Lind Global Fund II LP	13D/G 13D/G	3.2%	$2,211,858 557,143 shares	-$3,048,392	30 Jun 2025
VANGUARD CAPITAL MANAGEMENT LLC	13F Company 13F	2.2%	$591,708 374,499 shares	—	30 Jun 2026
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.3%	$360,380 228,042 shares	—	30 Jun 2026
VANGUARD FIDUCIARY TRUST CO	13F Company 13F	0.56%	$153,834 97,363 shares	—	30 Jun 2026
STATE STREET CORP	13F Company 13F	0.42%	$115,024 72,800 shares	—	30 Jun 2026
CITADEL ADVISORS LLC	13F Company 13F	0.41%	$113,904 72,091 shares	—	30 Jun 2026
BlackRock, Inc.	13F Company 13F	0.32%	$89,178 56,442 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.

Buys

Insiders: 0

Sells

Insiders: 0

Net

Shares: 0

Window

Last 12 months

4 rolling buckets

Buy value Sell value

Shares: 0 Shares: 0

Window (months)	Buy value	Sell value	Net value
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-13 of 13 reporting-owner rows connected to ABVC BIOPHARMA, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows

Largest Forms 3/4/5 holder

Chang-Jen Jiang

Net 12M change

Latest report

20 May 2022

Name	Relationship	Valuation	Report Date
Chang-Jen Jiang	Director	Mixed	02 Aug 2021
Norimi Sakamoto	Director	Mixed	02 Aug 2021
Tsang Ming Jiang	Director	Mixed	02 Aug 2021
Howard Doong	Chief Executive Officer	Mixed	02 Aug 2021
Yen-Hsin Chou	Director	Mixed	02 Aug 2021
Eugene Jiang	Chairman of the Board & CBO, Director	Mixed	02 Aug 2021
Shin-Yu Miao	Director	Mixed	02 Aug 2021
Tsung Shann Jiang	CSO and Director, Director	Mixed	02 Aug 2021
Shih-Chen Tseng	Director	Mixed	08 Nov 2021
Yoshinobu Odaira	Director	Mixed	02 Aug 2021
Chihliang An	Chief Financial Officer	Mixed	02 Aug 2021
Shuling Jiang	Director, 10%+ Owner	Mixed	20 May 2022
Chi-Hsin Richard King	Chief Scientific Officer	Mixed	02 Aug 2021

Recent insider transactions for ABVC BIOPHARMA, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

^* marks a reported price that did not pass the local price check.